Data Bridge Market Research analyzes that the global Artificial Intelligence (AI) in drug discovery market is expected to reach the value of USD 24,618.25 million by 2029, at a CAGR of 53.3% during the forecast period.
While preparing this professional and exhaustive ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY market research report, customer requirement has been kept into focus. Market type, size of the organization, availability on-premises, end-users’ organization type, and the availability in areas such as North America, South America, Europe, Asia-Pacific and Middle East Africa are considered while generating this report. A team of industry experts, talented researchers, innovative forecasters and knowledgeable analysts work with full dedication to endow clients with the quality research. Global ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY report also offers the details about the market drivers and market restraints for ABC industry that help in understanding rise or fall of the demand of particular product with respect to market conditions.
The information and analysis covered in the large scale ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY report brings into light the types of consumers, their preferences about the product, their buying intentions and their ideas for the step up of a product. Strategic aspects of the industry or market including product development and specification, technology, exploring niche growth opportunities, application modelling, and new geographical markets can be resolved with the huge information and data included in this market report. The ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY marketing report assists in determining and optimizing each stage in the lifecycle of industrial process that includes engagement, acquisition, retention, and monetization.
Get free sample report here:
Artificial Intelligence (AI) in Drug Discovery Market Analysis and Insights
Artificial Intelligence (AI) is expected to be a lucrative technology in the healthcare industry. The implementation of AI reduces RD gap in the drug manufacturing process and helps in targeted manufacturing of drug. Hence, biopharmaceutical companies are turning to AI to enhance their market share. AI for drug discovery is a technology that uses machines to simulate human intelligence to solve complicated challenges in the drug development procedure.
Global Artificial Intelligence (AI) In Drug Discovery Market Scope
APPLICATION
- Novel Drug Candidates
- Drug Optimization and Repurposing Preclinical Testing and Approval
- Drug Monitoring
- Finding New Diseases Associated Targets and Pathways
- Understanding Disease Mechanisms
- Aggregating and Synthesizing Information
- Formation Qualification of Hypotheses
- De Novo Drug Design
- Finding Drug Targets of an Old Drug
- Others
Based on application, the market is segmented into novel drug candidates, drug optimization and repurposing preclinical testing and approval, drug monitoring, finding new diseases associated targets and pathways, understanding disease mechanisms, aggregating and synthesizing information, formation qualification of hypotheses, de novo drug design, finding drug targets of an old drug and others.
TECHNOLOGY
- Machine Learning (ML)
- Deep Learning (DL)
- Natural Language Processing (NLP)
- Others
Based on technology, the market is segmented into Machine Learning (ML), Deep Learning (DL), Natural Language Processing (NLP) and others.
DRUG TYPE
- Small Molecule
- Large Molecule
Based on drug type, the market is segmented into small molecule and large molecule.
OFFERING
- Software
- Services
Based on offering, the market is segmented into software and services.
INDICATION
- Immuno-Oncology
- Neurodegenerative Diseases
- Cardiovascular Diseases
- Metabolic Diseases
- Others
Based on indication, the market is segmented into immuno-oncology, neurodegenerative diseases, cardiovascular diseases, metabolic diseases and others.
END USE
- Pharmaceutical Biotechnology Companies
- Contract Research Organizations (CROs)
- Research Centres And Academic Institutes
- Others
Global Artificial Intelligence (AI) in Drug Discovery Market Regional Analysis/Insights
- The countries covered in this market report are U.S.
- Canada
- Mexico
- Germany
- France
- K.
- Italy
- Spain
- Russia
- Turkey
- Belgium
- Netherlands
- Switzerland
- rest of Europe
- China
- Japan
- India
- South Korea
- Singapore
- Thailand
- Malaysia
- Australia New Zealand
- Philippines
- Indonesia
- rest of Asia-Pacific
- A.E
- Israel
- South Africa
- Saudi Arabia
- Egypt
- rest of Middle East and Africa
- Brazil
- Argentina and rest of South America.
Global Artificial Intelligence (AI) in Drug Discovery Market Share Analysis
Global Artificial Intelligence (AI) in drug discovery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in RD, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus on the global Artificial Intelligence (AI) in drug discovery market.
Key Players
- Some of the key players operating in the market are NVIDIA Corporation
- IBM Corp.
- Atomwise Inc.
- Microsoft
- Benevolent AI
- Aria Pharmaceuticals
- DEEP GENOMICS
- Exscientia
- Cloud
- Insilico Medicine
- Cyclica
- NuMedii
- Envisagenics
- Owkin Inc.
- BERG LLC
- Schrödinger
- XtalPi Inc. and BIOAGE Inc. among others.
Get Full access of Report
MAJOR TOC OF THE REPORT
- Chapter One: Introduction
- Chapter Two: Market Segmentation
- Chapter Three: Market Overview
- Chapter Four: Executive Summary
- Chapter Five: Premium Insights
- Chapter Six: Artificial Intelligence (AI) in drug discovery market
Get TOC Details
Related Reports
Nanoceramics Market – Industry Trends and Forecast to 2027
Polyfilm Market – Industry Trends and Forecast to 2028
Fire Protection Materials Market – Industry Trends and Forecast to 2029
Electric Vehicle Charging Stations Market
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
